Leo A. Niemeier, Haruko Kuffner Akatsu, Chi Song, Sally E. Carty, Steven P. Hodak, Linwah Yip, Robert L. Ferris, George C. Tseng, Raja R. Seethala, Shane O. LeBeau, Michael T. Stang, Christopher Coyne, Jonas T. Johnson, Andrew F. Stewart and Yuri E. Nikiforov A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma Cancer 118
Version of Record online: 31 AUG 2011 | DOI: 10.1002/cncr.26425
Thyroid papillary microcarcinoma (TPMC) is a common thyroid tumor with clinical behavior that is difficult to predict. A combined molecular-pathologic risk stratification model based on BRAF mutation status and 3 histopathologic features is a better predictor of extrathyroid spread of TPMC than either mutational or histopathologic findings alone.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field